175 related articles for article (PubMed ID: 37288612)
1. Association between parenteral nutrition-containing intravenous lipid emulsion and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial.
Gavin NC; Larsen E; Runnegar N; Mihala G; Keogh S; McMillan D; Ray-Barruel G; Rickard CM
JPEN J Parenter Enteral Nutr; 2023 Aug; 47(6):783-795. PubMed ID: 37288612
[TBL] [Abstract][Full Text] [Related]
2. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
3. Central Venous Access Device Complications in Patients Receiving Parenteral Nutrition in General Ward Settings: A Retrospective Analysis.
Martincich I; Cini K; Lapkin S; Lord H; Fernandez R
JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):1104-1111. PubMed ID: 31785017
[TBL] [Abstract][Full Text] [Related]
4. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
5. Does a Dedicated Lumen for Parenteral Nutrition Administration Reduce the Risk of Catheter-Related Bloodstream Infections? A Systematic Literature Review.
Gavin NC; Button E; Castillo MI; Ray-Barruel G; Keogh S; McMillan DJ; Rickard CM
J Infus Nurs; 2018; 41(2):122-130. PubMed ID: 29489708
[TBL] [Abstract][Full Text] [Related]
6. Does Parenteral Nutrition Increase the Risk of Catheter-Related Bloodstream Infection? A Systematic Literature Review.
Gavin NC; Button E; Keogh S; McMillan D; Rickard C
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):918-928. PubMed ID: 28654308
[TBL] [Abstract][Full Text] [Related]
7. Utility of Electronic Medical Records to Assess the Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections in Adult Hospitalized Patients.
Ippolito P; Larson EL; Furuya EY; Liu J; Seres DS
JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):929-34. PubMed ID: 24898208
[TBL] [Abstract][Full Text] [Related]
8. Central Line-Associated Bloodstream Infection in Patients With Hematologic Malignancy Receiving Parenteral Nutrition.
Lazarow H; Compher C; Ziegler MJ; Gilmar C; Kucharczuk CR; Landsburg DJ
JCO Oncol Pract; 2023 Aug; 19(8):571-576. PubMed ID: 37200611
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
[TBL] [Abstract][Full Text] [Related]
10. Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections.
Coffin SE; Klieger SB; Duggan C; Huskins WC; Milstone AM; Potter-Bynoe G; Raphael B; Sandora TJ; Song X; Zerr DM; Lee GM;
Infect Control Hosp Epidemiol; 2014 Nov; 35(11):1391-9. PubMed ID: 25333434
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Dandoy CE; Kim S; Chen M; Ahn KW; Ardura MI; Brown V; Chhabra S; Diaz MA; Dvorak C; Farhadfar N; Flagg A; Ganguly S; Hale GA; Hashmi SK; Hematti P; Martino R; Nishihori T; Nusrat R; Olsson RF; Rotz SJ; Sung AD; Perales MA; Lindemans CA; Komanduri KV; Riches ML
JAMA Netw Open; 2020 Jan; 3(1):e1918668. PubMed ID: 31913492
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications associated with parenteral nutrition in intensive care unit and non-intensive care unit patients.
Comerlato PH; Stefani J; Viana MV; Viana LV
Braz J Infect Dis; 2020; 24(2):137-143. PubMed ID: 32205124
[TBL] [Abstract][Full Text] [Related]
14. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
15. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
Epstein L; See I; Edwards JR; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
[TBL] [Abstract][Full Text] [Related]
17. Impact of removing mucosal barrier injury laboratory-confirmed bloodstream infections from central line-associated bloodstream infection rates in the National Healthcare Safety Network, 2014.
See I; Soe MM; Epstein L; Edwards JR; Magill SS; Thompson ND
Am J Infect Control; 2017 Mar; 45(3):321-323. PubMed ID: 27856070
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Analysis of Bloodstream Infections in Pediatric Allogeneic Stem Cell Transplant Recipients: The Role of Central Venous Catheters and Mucosal Barrier Injury.
Balian C; Garcia M; Ward J
J Pediatr Oncol Nurs; 2018 May; 35(3):210-217. PubMed ID: 29560765
[TBL] [Abstract][Full Text] [Related]
19. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.
Elgarten CW; Otto WR; Shenton L; Stein MT; Horowitz J; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Modi AJ; Mian A; Mody R; Morgan E; Raetz EA; Verma A; Winick N; Wilkes JJ; Yu JC; Aplenc R; Fisher BT; Getz KD
Infect Control Hosp Epidemiol; 2023 Feb; 44(2):222-229. PubMed ID: 35465865
[TBL] [Abstract][Full Text] [Related]
20. Parenteral Nutrition Total Energy Dosing and Risk for Central Line-Associated Bloodstream Infection: A Case-Control Study.
Rosen AN; Ross RC; Tran KK; Franck AJ
J Pharm Pract; 2023 Aug; 36(4):777-782. PubMed ID: 35323065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
